MedTrace Logo

PROgnostic Value of MicroParticles and Markers of Hemostasis in TIA and Ischemic Stroke

NCT05524506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 249

Last updated 2022-09-01

No results posted yet for this study

Summary

The purpose is to investigate if different microparticles and markers of hemostasis predict outcome after TIA or ischemic stroke and to study the association between these variables and stroke subtype or etiology.

Conditions

  • Brain Ischemia
  • Cerebral Ischemia
  • Extracellular Vesicles
  • Hemostasis
  • Prognosis

Sponsors & Collaborators

  • Danderyd Hospital

    collaborator OTHER

  • Stockholm South General Hospital

    collaborator OTHER

  • Karolinska Institutet

    lead OTHER

Principal Investigators

  • Mårten Rosenqvist, Prof · Karolinska Institutet

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2014-12-31
Completion
2021-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05524506 on ClinicalTrials.gov